Mariya A. Smetanina

Dr. Mariya A. Smetanina

orcid

Research Focus & Metrics

Academic Career Length

20Years (2007-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
2 August 2018 in Epigenomics
Verified
Journal Article
Closed access
MSMariya A. Smetanina
Mariya A. Smetanina
AKAlexander E Kel
Alexander E Kel
KSKsenia S Sevost’iAnova
Ksenia S Sevost’iAnova
IMIgor V Maiborodin
Igor V Maiborodin
ASAndrey I Shevela
Andrey I Shevela
MFMaxim L Filipenko
Maxim L Filipenko
Aim: To integrate transcriptomic and DNA-methylomic measurements on varicose versus normal veins using a systems biological analysis to shed light on the interplay between genetic and epigenetic factors. Materials & methods: Differential expression and methylation were measured using microarrays, supported by real-time quantitative PCR and immunohistochemistry confirmation for relevant gene products. A systems biological ‘upstream analysis’ was further applied. Results: We identified several potential key players contributing to extracellular matrix remodeling in varicose veins. Specifically, our analysis suggests MFAP5 acting as a master regulator, upstream of integrins, of the cellular network affecting the varicose vein condition. Possible mechanism and pathogenic model were outlined. Conclusion: A coherent model proposed incorporates the relevant signaling networks and will hopefully aid further studies on varicose vein pathogenesis.

1 June 2018 in Gene
Verified
Journal Article
Closed access
ASAlexandra Shadrina
Alexandra Shadrina
YTYakov Tsepilov
Yakov Tsepilov
ESEkaterina Sokolova
Ekaterina Sokolova
MSMariya A. Smetanina
Mariya A. Smetanina
EVElena Voronina
Elena Voronina
MFMaxim Filipenko
Maxim Filipenko

16 April 2018 in Clinical Genetics
Verified
Journal Article
Closed access
PDF file
ASA. Shadrina
A. Shadrina
YTYakov Tsepilov
Yakov Tsepilov
MSMariya A. Smetanina
Mariya A. Smetanina
EVE. Voronina
E. Voronina
ESE. Seliverstov
E. Seliverstov
MFM. Filipenko
M. Filipenko

28 September 2015 in Clinical and Experimental Medicine
Verified
Journal Article
Closed access
PDF file
ESEkaterina Sokolova
Ekaterina Sokolova
ASAlexandra S. Shadrina
Alexandra S. Shadrina
KSKseniya S. Sevost’iAnova
Kseniya S. Sevost’iAnova
ASAndrey I. Shevela
Andrey I. Shevela
ESEvgenii Yu. Soldatsky
Evgenii Yu. Soldatsky
Maksim Leonidovich FilipenkoMaksim Leonidovich Filipenko
Maksim Leonidovich Filipenko

25 September 2017 in Bulletin of Experimental Biology and Medicine
Verified
Journal Article
Closed access
PDF file
ASA. S. Shadrina
A. S. Shadrina
MSMariya A. Smetanina
Mariya A. Smetanina
KSK. S. Sevost’yAnova
K. S. Sevost’yAnova
ASA. I. Shevela
A. I. Shevela
ESE. I. Seliverstov
E. I. Seliverstov
MFM. L. Filipenko
M. L. Filipenko

30 March 2020 in Annals of the Russian academy of medical sciences
Verified
Journal Article
Open access
IZIgor A. Zolotukhin
Igor A. Zolotukhin
OPOlga Porembskaya
Olga Porembskaya
MSMariya A. Smetanina
Mariya A. Smetanina
ASAleksandr V. Sazhin
Aleksandr V. Sazhin
Maksim Leonidovich FilipenkoMaksim Leonidovich Filipenko
Maksim Leonidovich Filipenko
AKAleksandr I. Kirienko
Aleksandr I. Kirienko
Varicose veins of the lower limbs are one of the most common and wide-spread pathology all around the world. What triggers the specific changes in a vein wall still remains unclear as well as what happens in the layers of the vein wall after the disease starts. The aim of the article is to analyze published data and results of researches on epidemiology, genetics, cellular and molecular mechanisms underlying varicose veins pathogenesis. It is now commonly accepted that vein wall changes in patients with varicose veins result from vein-specific inflammation. This process includes leukocytes adhesion to venous endothelium with their subsequent migration into the vein wall and surrounding tissues. Activated leukocytes express a number of molecules that lead to vein wall remodeling and dilation. Comprehensive assessment of the epidemiological data on the prevalence of varicose veins and risk factors, of the findings from genetic studies, of data on molecular-cell interactions as well as results of various surgical interventions in patients with varicose veins, shows that remodeling is a reversible process that can be stopped and reversed by different stimuli including some chemical substances. For the first time in the literature, the authors assume that varicose veins can be successfully cured pharmacologically with no surgical interventions needed.